How Receptor Agonists Work
Learn how agonist drugs bind to receptors and activate downstream signaling cascades.
Introduction
Receptor agonists are drugs that bind to cellular receptors and mimic the action of endogenous ligands, activating signal transduction pathways. They form the backbone of pharmacotherapy, from beta-agonists in asthma to opioid agonists in pain management. Understanding how agonists interact with receptors is fundamental to predicting drug potency, efficacy, and therapeutic index.
Receptor Binding
Agonists interact with receptors through complementary molecular surfaces involving hydrogen bonds, ionic interactions, van der Waals forces, and hydrophobic contacts. Binding depends on affinity—the strength of the drug-receptor interaction, quantified by the dissociation constant (Kd). A lower Kd means higher affinity. The binding event is typically reversible and governed by the law of mass action: at equilibrium, the rate of association equals the rate of dissociation.
Activation and Efficacy
Upon binding, agonists induce a conformational change in the receptor that switches it from an inactive (R) to an active (R*) state. This property is called intrinsic efficacy. Full agonists produce the maximal possible response (efficacy = 1), while partial agonists produce a submaximal response regardless of concentration.
The dose-response relationship follows a sigmoidal curve when plotted on a log scale. EC50 is the concentration producing 50% of the maximal effect and reflects both affinity and efficacy. Potency (EC50) and efficacy (Emax) are independent parameters—a drug can be highly potent but have low maximal efficacy.
Signal Transduction
Activated receptors trigger intracellular cascades that vary by receptor type. G-protein coupled receptors (GPCRs) activate heterotrimeric G-proteins that modulate second messengers like cAMP, IP3, and DAG. Receptor tyrosine kinases autophosphorylate and recruit adaptor proteins such as Grb2 and SOS, initiating MAPK cascades. Ligand-gated ion channels open directly upon agonist binding, allowing ion flux within milliseconds—the fastest signaling mechanism.
Therapeutic Applications
Agonists are used when receptor activation produces a desired therapeutic outcome:
- Salbutamol: Beta-2 agonist for bronchodilation in asthma
- Morphine: Mu-opioid agonist for severe pain relief
- Sumatriptan: 5-HT1B/1D agonist for acute migraine
- Insulin: Insulin receptor agonist for diabetes mellitus
- Dopamine: D1 agonist for cardiogenic shock
Key Takeaways
- Agonists bind receptors and trigger conformational activation to the R* state
- Affinity (Kd) and efficacy together determine drug potency and maximal response
- Full agonists reach maximal response; partial agonists have a ceiling effect
- Different receptor families (GPCRs, kinases, ion channels) use distinct signaling mechanisms